English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
抽象的
A Double Observational Studies Research on the Advantages of Plerixafor for Mobilising Peripheral Blood Stem Cells before Autologous Transplantation
Katherine Barkey
Hematopoietic stem cells must be propelled from the bone marrow to the peripheral circulation for collecting prior to autologous stem cell transplantation (ASCT). Plerixafor, an antagonist of C-X-C chemokine receptor type 4, is employed to boost stem cell harvests. Plerixafor's impact on post-ASCT results, however, is still unknown.
免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证。